All In Biotech

Investigational drug · Phase 3

Pralurbactam

Not approved by FDA. In 3 industry-sponsored Phase 2 or 3 trials that are active or finished in the last two years, most often for Hospital-acquired Bacterial Pneumonia (HABP), Ventilator-associated Bacterial Pneumonia (VABP), Complicated Intra-abdominal Infection (cIAI).

Phase 3

Last checked: Nov 19, 2026Latest source record: Feb 17, 2026 (newest trial update)Source: ClinicalTrials.govMethods & limitations

Highest phase

Phase 3

Industry-sponsored trials

Phase 2 and 3 trials

3

3 still active

All registered trials

3

Any phase or sponsor naming "Pralurbactam"

First trial start

2024

Oct 31, 2024

Sponsors

Lead sponsors of its Phase 2 and 3 trials.

All registered trials by phase

Every ClinicalTrials.gov drug study naming "Pralurbactam", any sponsor or status.

Conditions studied

As listed on its trial records.

  • Hospital-acquired Bacterial Pneumonia (HABP)
  • Ventilator-associated Bacterial Pneumonia (VABP)
  • Complicated Intra-abdominal Infection (cIAI)
  • Complicated Urinary Tract Infection (cUTI)
  • Bloodstream Infection (BSI)
  • Intra-abdominal Infections
  • Hospital-acquired Bacterial Pneumonia and Ventilator-associated Bacterial Pneumonia

Approved drugs for the same conditions: Urinary tract infection · Pneumonia · Infectious disease and vaccines · Kidney and urology

Largest trials

Live from ClinicalTrials.gov: studies naming "Pralurbactam" as an intervention, largest first.

All trials

Newest research

PubMed records naming it or its code names, newest first.

All 1 on PubMed

Also in development for Hospital-acquired Bacterial Pneumonia (HABP)

  • HRS-8427Phase 32 trials

    Jiangsu HengRui Medicine Co., Ltd. · Complicated Urinary Tract Infection(cUTI), Including Acute Pyelonephritis(AP), Hospital-acquired Bacterial Pneumonia (HABP), Ventilator-associated Bacterial Pneumonia (VABP)

  • YK-1169Phase 31 trial

    Nanjing Yoko Biomedical Co., Ltd. · Hospital-acquired Bacterial Pneumonia (HABP), Ventilator-associated Bacterial Pneumonia (VABP)

  • ASK0912Phase 21 trial

    Jiangsu Aosaikang Pharmaceutical Co., Ltd. · Ventilator-associated Bacterial Pneumonia (VABP), Hospital-acquired Bacterial Pneumonia (HABP)

Names are merged from how sponsors list this drug on ClinicalTrials.gov, so an alias can occasionally belong to a related compound. Development status changes faster than registry records do.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.